Medigus Ltd WT Performance
MDGSWDelisted Stock | USD 0.02 0.00 0.00% |
The company secures a Beta (Market Risk) of 3.44, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Medigus will likely underperform. Medigus Ltd WT right now secures a risk of 0.0%. Please verify Medigus Ltd WT total risk alpha, as well as the relationship between the downside variance and day median price , to decide if Medigus Ltd WT will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Medigus Ltd WT has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Medigus is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
Begin Period Cash Flow | 24 M | |
Free Cash Flow | -5.7 M |
Medigus |
Medigus Relative Risk vs. Return Landscape
If you would invest 2.13 in Medigus Ltd WT on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Medigus Ltd WT or generate 0.0% return on investment over 90 days. Medigus Ltd WT is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than Medigus, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
Medigus Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medigus' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medigus Ltd WT, and traders can use it to determine the average amount a Medigus' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
MDGSW |
Based on monthly moving average Medigus is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medigus by adding Medigus to a well-diversified portfolio.
Medigus Fundamentals Growth
Medigus Stock prices reflect investors' perceptions of the future prospects and financial health of Medigus, and Medigus fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medigus Stock performance.
Revenue | 91.86 M | |||
EBITDA | (11.99 M) | |||
Total Debt | 10.13 M | |||
Cash Flow From Operations | (5.66 M) | |||
Total Asset | 97.65 M | |||
Retained Earnings | (85.59 M) | |||
About Medigus Performance
Evaluating Medigus' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Medigus has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medigus has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Medigus Ltd WT performance evaluation
Checking the ongoing alerts about Medigus for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medigus Ltd WT help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Medigus Ltd WT is not yet fully synchronised with the market data | |
Medigus Ltd WT has some characteristics of a very speculative penny stock | |
Medigus Ltd WT has a very high chance of going through financial distress in the upcoming years | |
The company reported the revenue of 91.86 M. Net Loss for the year was (10.1 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Medigus generates negative cash flow from operations |
- Analyzing Medigus' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medigus' stock is overvalued or undervalued compared to its peers.
- Examining Medigus' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medigus' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medigus' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medigus' stock. These opinions can provide insight into Medigus' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Medigus Stock
If you are still planning to invest in Medigus Ltd WT check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigus' history and understand the potential risks before investing.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |